ArticleAnesthesiology2026
Inpatient Cost of Complications after Total Hip and Knee Arthroplasty.
Article in Anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07669064 (ORAL-PROTECT I), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
ORAL-PROTECT I: Oral Asepsis for Preoperative Reduction Of Tracheal Bacterial Establishment, Colonization, and Transmission
Who cites it
3 citing papers in PubMed.
- Artificial Intelligence Applications in Implant Positioning, Dislocation Risk Prediction, and Surgical Indications in Orthopaedic Surgery.Bioengineering (Basel, Switzerland) · 2026Review
- Patient perception of robotic-assisted arthroplasty: how confidence in expected outcomes influences recovery.Annals of joint · 2026Article
- Perioperative gabapentinoid use during total knee arthroplasty is associated with higher rates of postoperative complications compared to no use.Orthopedic reviews · 2026Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMore than 1 million hip and knee total joint arthroplasties (THAs and TKAs) are performed annually in the United States. While major perioperative complications are relatively uncommon, they may substantially increase healthcare expenditures. The economic impact of individual complications, however, remains poorly defined. This study aimed to assess the effect of major complications on hospital costs and length of stay (LOS).
methodsThis study analyzed data from 2,361,402 THA/TKA patients in the Premier Healthcare claims database (2006 to 2022). The exposure was the occurrence of major postoperative complications ( e.g. , cardiac, pulmonary, renal, gastrointestinal, infectious, central nervous system, and thromboembolic complications), evaluated individually and in clusters (two coinciding or three or more coinciding). The primary outcome was total cost of hospital stay. Generalized estimating equation models compared costs across groups, reported as percent change with 95% CI.
resultsMedian costs without complications were $16,802 (interquartile range [IQR], $13,731 to $20,838) for TKA and $17,250 (IQR, $14,072 to $21,355) for THA. In TKA, the highest costs occurred with three or more complications ($35,477; IQR, $26,078 to $52,071), sepsis ($30,633; IQR, $21,748 to $44,530), and myocardial infarction ($28,908; IQR, $21,805 to $38,744). Multivariable models confirmed the greatest adjusted increases with 3 or more complications (+136%), sepsis (+88%), and myocardial infarction (+73%) at the patient level. Frequent complications such as renal failure (+26%), pulmonary complications (+23%), and intensive care unit admission (+61%) emerged as leading drivers of overall costs. LOS accounted for a substantial share of additional costs.
conclusionsIn this large national cohort, perioperative complications substantially increased hospital costs, largely via prolonged LOS. Although sepsis, stroke, and myocardial infarction were most expensive per case, the overall healthcare burden was driven by frequent complications and resource use, including intensive care unit admission, acute renal failure, pulmonary complications, mechanical ventilation, and concurrent complications. These findings suggest that targeting frequent complications and resource intensive care processes may yield the greatest impact on reducing hospital expenditures in arthroplasty surgery.
Indexed as
Identifiers
41264388What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.